Ansa bio appoints dr. matthew mcmanus as chair of the board

Emeryville, calif.--(business wire)-- #dna--ansa biotechnologies, a pioneer of next-generation dna synthesis, today announced the appointment of matthew f. mcmanus, m.d, ph.d., as independent director and chairperson of the company's board of directors. dr. mcmanus brings decades of experience in the life sciences industry to the board. he was most recently evp and chief operating officer at azenta (nasdaq:azta), a global life sciences tools, products, and services company. prior to azenta, dr.
AZTA Ratings Summary
AZTA Quant Ranking